Tag: Animal

Cell Expansion Market Worth $39.7 Billion By 2027

The global cell expansion market size is expected to reach USD 39.7 billion by 2027 registering a CAGR of 9.4%, according to a new report by Grand View Research, Inc. Cell expansion techniques are increasingly employed for the development of cellular and gene therapies from a single cord blood collection. These techniques can also be used for the expansion of stored Stem Cells (SCs) for the development of cancer therapies. Therefore, significant developments in cord blood SCs expansion technologies are expected to boost market growth.

Companies have made heavy investments for the expansion of tissue-engineered products and the development of biologics. For instance, in March 2019, Merck KGaA invested USD 168 million for the expansion of its biologics manufacturing facility in Switzerland. Such initiatives are expected to boost the demand for solutions required for biologic development, thereby leading to market growth.

Bioreactors are fundamental tools in this market. Extensive research studies related to the applications of bioreactor engineering approaches have led to the incorporation of novel culture technologies. Moreover, the combined use of automated bioreactors with the microcarrier technology leads to an efficient expansion and enrichment of the cancer SCs. As a result, these approaches have gained immense traction in this market.

Click the link below:
https://www.grandviewresearch.com/industry-analysis/cell-expansion-market

Further key findings from the report suggest:

  • Broad portfolio of automated expansion systems along with improvements in bioreactor design for large-scale bioproduction results in the lucrative growth opportunity for instruments
  • The microbial cells segment is expected to witness the fastest growth rate owing to the implementation of high-throughput cultivation approaches and techniques that avoid the formation of biofilms
  • Biopharmaceuticals segment held the largest revenue share in 2019 due to growth in the demand for biosimilars, continuous R&D investments in biomanufacturing, and rise in the number of approvals for biologics
  • Asia Pacific is anticipated to grow at the maximum CAGR from 2020 to 2027 due to presence of several consortiums that focus on the evolving fields in the biomedical industry
  • For instance, in November 2019, the Cell & Gene Therapy Asia 2019 held in Japan focused on the evolving field of SCs for their deployment in pharmaceutical discovery and cellular therapies

Digestive Enzyme Supplements Market Size Worth $1.6 Billion By 2025

The global digestive enzyme supplements market size is expected to reach USD 1.6 billion by 2025, according to a new report published by Grand View Research, Inc. Growing consumer awareness regarding the severity of digestive disorders coupled with the need for good health is expected to stimulate industry growth over the forecast period. The increasing incidence of gastrointestinal tract diseases, such as irritable bowel syndrome, constipation, inflammatory bowel disease, and gastroesophageal reflux disease, has raised concerns towards stomach health, which in turn is anticipated to fuel product growth.

Digestive enzyme supplements have to comply with various regulatory bodies including the U.S. Food and Drug Administration, Dietary Supplement Health and Education Act of 1994, and Natural Health Products Regulations for manufacturing and use. Increasing number of gymnasiums and fitness centers in emerging markets including China and India on account of rising awareness towards muscle improvement and reducing fat content among individuals will propel product demand.

Click the link below:
http://www.grandviewresearch.com/industry-analysis/digestive-enzyme-supplements-market

Further key findings from the report suggest:

  • Plant-based enzymes accounted for 41.3% of the overall revenue in 2015 and are expected to foresee considerable growth as these products aid in reducing acid indigestion, heartburn, reflux, and other digestive disturbances. Furthermore, the usability of these products across a wide range of pH levels is likely to expand their application.
  • Europe is expected to observe substantial revenue rise at a CAGR of 7.3% from 2016 to 2025. Easy availability of the product owing to the presence of a large number of supermarket chains along with increasing awareness regarding gastrointestinal problems is expected to fuel digestive enzyme supplements market size over the next nine years.
  • Central and South America is expected to foresee substantial growth owing to increasing prevalence of digestive disorders in the region. Increasing consumer awareness regarding the harm caused by the digestive system due to the lack of supplements and nutrients in the human body is anticipated to fuel expansion.
  • The industry is highly competitive owing to the presence of various large and small scale manufacturers. Key players including Klaire Labs, National Enzyme Company, ProteoZymes, Metagenics, and Douglas Labs are focusing on increasing their industry share along with profitability through product innovation and empowering their R&D activities. Companies are increasing expenditure for the establishment of strategic partnerships with retail chain companies.
  • In November 2015, Vox Nutrition launched a new private label digestive enzyme supplement, Digestion Enzyme Pro Blend. The product aims to enhance nutrition absorption, assist the body in breaking down difficult proteins, supports healthy digestion, and helps in relieving reactions of common food intolerances.